Novel treatments for dry eye syndrome

Curr Opin Pharmacol. 2024 Jan 25;75:102431. doi: 10.1016/j.coph.2024.102431. Online ahead of print.ABSTRACTDry eye syndrome (DES) is a prevalent and multifactorial disease that leads to a self-perpetuating cycle of inflammation and damage to the ocular surface. This results in symptoms such as redness, burning, and blurred vision, which can negatively affect a patient's quality of life. While treatments are available to manage DES, they only temporarily relieve symptoms. Furthermore, long-term use of certain medications can cause harm to the ocular surface. Therefore, there is a need for safer and effective treatments for DES. This review highlights the latest advancements in DES therapy, providing valuable insights into ongoing efforts to improve patient outcomes.PMID:38277944 | DOI:10.1016/j.coph.2024.102431
Source: Current Opinion in Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research